Proteomic analysis of human substantia nigra identifies novel candidates involved in parkinson's disease pathogenesis

Proteomics

Volumn 14, Issue 6, 2014, Pages 784-794

  Licker, Virginie ^a   Turck, Natacha ^a   Kövari, Enikö ^b   Burkhardt, Karim ^b   Côte, Mélanie ^a   Surini Demiri, Maria ^b   Lobrinus, Johannes A ^b   Sanchez, Jean Charles ^a   Burkhard, Pierre R ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Biomedicine; Nebulette; Parkinson's disease; Postmortem tissue; Substantia nigra

Indexed keywords

FERRITIN; GAMMA GLUTAMYL HYDROLASE; PROTEIN; SEIPIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEOMICS; SUBSTANTIA NIGRA; WESTERN BLOTTING;

BIOMEDICINE; NEBULETTE; PARKINSON'S DISEASE; POSTMORTEM TISSUE; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROTEOME; PROTEOMICS; SUBSTANTIA NIGRA;

EID: 84895767965     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300342     Document Type: Article

References (46)

1. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q. et al., Alpha-synuclein in Lewy bodies. Nature 1997, 388, 839-840.
2. Licker, V., Kovari, E., Hochstrasser, D. F., Burkhard, P. R., Proteomics in human Parkinson's disease research. J. Proteomics 2009, 73, 10-29.
3. Basso, M., Giraudo, S., Corpillo, D., Bergamasco, B. et al., Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 2004, 4, 3943-3952.
4. Jin, J., Hulette, C., Wang, Y., Zhang, T. et al., Proteomic identification of a stress protein, mortalin/mthsp70/grp75: relevance to Parkinson disease. Mol. Cell Proteomics 2006, 5, 1193-1204.
5. Kitsou, E., Pan, S., Zhang, J., Shi, M. et al., Identification of proteins in human substantia nigra. Prot. Clin. Appl. 2008, 2, 776-782.
6. Shi, M., Jin, J., Wang, Y., Beyer, R. P. et al., Mortalin: a protein associated with progression of Parkinson disease? J. Neuropathol. Exp. Neurol. 2008, 67, 117-124.
7. Licker, V., Cote, M., Lobrinus, J. A., Rodrigo, N. et al., Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease. J. Proteomics 2012, 75, 4656-4667.
8. Werner, C. J., Heyny-von Haussen, R., Mall, G., Wolf, S., Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci. 2008, 6, 8.
9. van Dijk, K. D., Berendse, H. W., Drukarch, B., Fratantoni, S. A. et al., The proteome of the locus ceruleus in Parkinson's disease: relevance to pathogenesis. Brain Pathol. 2012, 22, 485-498.
10. Hughes, A. J., Daniel, S. E., Ben-Shlomo, Y., Lees, A. J., The accuracy of diagnosis of Parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125, 861-870.
11. Dickson, D., Fujishiro, H., DelleDonne, A., Menke, J. et al., Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol. 2008, 115, 437-444.
12. Dayon, L., Hainard, A., Licker, V., Turck, N. et al., Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Anal. Chem. 2008, 80, 2921-2931.
13. Dayon, L., Pasquarello, C., Hoogland, C., Sanchez, J.-C., Scherl, A., Combining low- and high-energy tandem mass spectra for optimized peptide quantification with isobaric tags. J. Proteomics 2010, 73, 769-777.
14. Gluck, F., Hoogland, C., Antinori, P., Robin, X. et al., EasyProt-an easy-to-use graphical platform for proteomics data analysis. J. Proteomics 2013, 79, 146-160.
15. Breitwieser, F. P., Muller, A., Dayon, L., Kocher, T. et al., General statistical modeling of data from protein relative expression isobaric tags. J. Proteome Res. 2011, 10, 2758-2766.
16. Mi, H., Dong, Q., Muruganujan, A., Gaudet, P. et al., PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res. 2010, 38, D204-D210.
17. Huang, D. W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols 2009, 4, 44-57.
18. Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J. et al., DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4, P3.
19. Maere, S., Heymans, K., Kuiper, M., BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21, 3448-3449.
20. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
21. Vizcaino, J. A., Côté, R. G., Csordas, A., Dianes, J. A. et al., The proteomics identifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2013, 41, D1063-D1069.
22. Burkard, T. R., Planyavsky, M., Kaupe, I., Breitwieser, F. P. et al., Initial characterization of the human central proteome. BMC Syst. Biol. 2011, 5, 17.
23. Adachi, J., Kumar, C., Zhang, Y., Mann, M., In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics. Mol. Cell Proteomics 2007, 6, 1257-1273.
24. Tan, H. T., Tan, S., Lin, Q., Lim, T. K. et al., Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells. Mol. Cell Proteomics 2008, 7, 1174-1185.
25. Faucheux, B. A., Martin, M. E., Beaumont, C., Hunot, S. et al., Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J. Neurochem. 2002, 83, 320-330.
26. Ito, D., Suzuki, N., Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain 2009, 132, 8-15.
27. Sulzer, D., Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci. 2007, 30, 244-250.
28. Wilson, C. J., Callaway, J. C., Coupled oscillator model of the dopaminergic neuron of the substantia nigra. J. Neurophysiol. 2000, 83, 3084-3100.
29. Olakanmi, O., Stokes, J. B., Britigan, B. E., Acquisition of iron bound to low molecular weight chelates by human monocyte-derived macrophages. J. Immunol. 1994, 153, 2691-2703.
30. Pappas, C. T., Bliss, K. T., Zieseniss, A., Gregorio, C. C., The Nebulin family: an actin support group. Trends Cell Biol. 2011, 21, 29-37.
31. Li, B., Zhuang, L., Trueb, B., Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J. Biol. Chem. 2004, 279, 20401-20410.
32. Deng, X. A., Norris, A., Panaviene, Z., Moncman, C. L., Ectopic expression of LIM-nebulette (LASP2) reveals roles in cell migration and spreading. Cell Motil. Cytoskel. 2008, 65, 827-840.
33. Gilmore, A. P., Anoikis. Cell Death Differ. 2005, 12, 1473-1477.
34. Galloway, P. G., Mulvihill, P., Perry, G., Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am. J. Pathol. 1992, 140, 809-822.
35. Sousa, V. L., Bellani, S., Giannandrea, M., Yousuf, M. et al., alpha-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics. Mol. Biol. Cell 2009, 20, 3725-3739.
36. McMurray, C. T., Neurodegeneration: diseases of the cytoskeleton? Cell. Death. Differ. 2000, 7, 861-865.
37. Wakabayashi, K., Tanji, K., Odagiri, S., Miki, Y. et al., The Lewy body in Parkinson's disease and related neurodegenerative disorders. Mol. Neurobiol. 2013, 47, 495-508.
38. Leverenz, J. B., Umar, I., Wang, Q., Montine, T. J. et al., Proteomic identification of novel proteins in cortical Lewy bodies. Brain Pathol. 2007, 17, 139-145.
39. Bonneh-Barkay, D., Wiley, C. A., Brain extracellular matrix in neurodegeneration. Brain Pathol. 2009, 19, 573-585.
40. Rite, I., Machado, A., Cano, J., Venero, J. L., Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J. Neurochem. 2007, 101, 1567-1582.
41. Burton, J. L., Underwood, J., Clinical, educational, and epidemiological value of autopsy. Lancet 2007, 369, 1471-1480.
42. Crecelius, A., Gotz, A., Arzberger, T., Frohlich, T. et al., Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE. Proteomics 2008, 8, 1276-1291.
43. Sowell, R. A., Owen, J. B., Butterfield, D. A., Proteomics in animal models of Alzheimer's and Parkinson's diseases. Ageing Res. Rev. 2009, 8, 1-17.
44. Potashkin, J. A., Blume, S. R., Runkle, N. K., Limitations of animal models of Parkinson's disease. Parkinsons Dis. 2011, 2011, 658083.
45. Beal, M. F., Parkinson's disease: a model dilemma. Nature 2010, 466, 8-10.
46. Licker, V., Burkhard, P. R., Neuroproteomics and Parkinson's disease: don't forget human samples. Expert Rev. Proteomics 2011, 8, 291-294.